249 related articles for article (PubMed ID: 25115396)
1. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.
Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N
Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396
[TBL] [Abstract][Full Text] [Related]
2. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
[TBL] [Abstract][Full Text] [Related]
3. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
Kojima S; Enokida H; Yoshino H; Itesako T; Chiyomaru T; Kinoshita T; Fuse M; Nishikawa R; Goto Y; Naya Y; Nakagawa M; Seki N
J Hum Genet; 2014 Feb; 59(2):78-87. PubMed ID: 24284362
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
[TBL] [Abstract][Full Text] [Related]
7. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma.
Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H
J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580
[TBL] [Abstract][Full Text] [Related]
8. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
[TBL] [Abstract][Full Text] [Related]
9. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
12. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
Goto Y; Kojima S; Kurozumi A; Kato M; Okato A; Matsushita R; Ichikawa T; Seki N
Br J Cancer; 2016 May; 114(10):1135-44. PubMed ID: 27070713
[TBL] [Abstract][Full Text] [Related]
13. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.
Kojima S; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nohata N; Fuse M; Ichikawa T; Naya Y; Nakagawa M; Seki N
Br J Cancer; 2012 Jan; 106(2):405-13. PubMed ID: 22068816
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.
Nishikawa R; Goto Y; Kojima S; Enokida H; Chiyomaru T; Kinoshita T; Sakamoto S; Fuse M; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2014 Jul; 45(1):401-10. PubMed ID: 24820027
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
18. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ
BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]